Zhejiang Ausun Pharmaceutical Co., Ltd.

SSE:603229.SS

9.18 (CNY) • At close June 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q1
Revenue 306.636111.275196.126188.831299.057142.958202.946206.166262.55186.634196.553176.247205.113140.015144.033141.657143.993107.37991.997130.40379.471104.48574.17970.88658.36589.63338.1666.21349.879100.49249.16251.58238.95177.44748.08332.20841.10445.166
Cost of Revenue 119.55670.50192.35175.604125.52582.86387.43788.918107.93485.61498.74195.44890.99162.70974.14656.51564.20646.239.88655.70736.50252.10233.41433.37629.57848.46921.5537.39827.56740.11721.74716.816.44536.64723.44712.12816.54222.289
Gross Profit 187.08140.773103.775113.227173.53260.095115.51117.248154.616101.01997.81280.799114.12277.30669.88785.14279.78761.17952.1174.69642.96952.38340.76537.50928.78741.16416.6128.81422.31260.37527.41534.78222.50740.824.63620.0824.56222.877
Gross Profit Ratio 0.610.3660.5290.60.580.420.5690.5690.5890.5410.4980.4580.5560.5520.4850.6010.5540.570.5660.5730.5410.5010.550.5290.4930.4590.4350.4350.4470.6010.5580.6740.5780.5270.5120.6230.5980.507
Reseach & Development Expenses 28.30437.80423.60215.76223.2513.17725.78426.4421.46214.47623.82918.16710.619.516.03417.68615.6047.9528.62619.414.79218.56113.7497.5317.90511.4249.0828.8585.0110.7827.72611.334023.484010.51604.246
General & Administrative Expenses 20.82-20.9151.284-0.41820.005-26.10649.8049.0819.326-34.39461.823-1.58713.931-22.45943.417-0.84913.655-16.85714.5681.54811.451-6.38111.719-1.7679.214-10.10310.472-5.31111.124-24.98515.953-3.2399.647-22.19811.90310.1719.1299.324
Selling & Marketing Expenses 3.316-2.0445.5034.6662.3847.6742.246.6411.5859.1987.5332.651.3783.1921.6051.4440.9111.3260.6463.1371.6723.2091.8682.6621.2532.4591.1111.8690.9262.9060.7981.2150.431.5490.8821.1230.8530.963
SG&A 24.136-57.39856.79930.94230.12720.23252.04415.72120.91-25.19669.3561.06315.308-19.26745.0220.59514.565-15.53115.2144.68613.123-3.17213.5870.89510.467-7.64411.583-3.44112.049-22.07816.751-2.02510.077-20.64912.78511.2939.98310.288
Other Expenses -2.12931.1880-1.566-0.34723.4090.427-0.0010.16753.932-29.28926.8820.5343.458-0-0.550.094-4.846-0.362-0.001-0.597-0.0740.01-0.363-0.0792.134-0.250.759-0.002-1.511-0.144-2.0552.0530.4581.4230.6610.0980.017
Operating Expenses 50.31136.9451.57848.26953.37726.66846.15372.19142.5443.21263.89646.11226.44342.37641.81838.14630.2921.52423.05439.27526.46936.78627.4519.03516.48423.93121.02821.80411.62426.73815.79514.33710.36318.59312.8211.29410.25310.79
Operating Income 136.773.69252.33864.958120.15534.96472.20474.653109.00254.36861.94960.27981.11937.75829.98543.39149.01822.73816.09734.82322.9565.52820.43126.7268.42512.0048.26724.5592.41524.3757.81716.34311.75325.92914.3379.12113.22811.438
Operating Income Ratio 0.4460.0330.2670.3440.4020.2450.3560.3620.4150.2910.3150.3420.3950.270.2080.3060.340.2120.1750.2670.2890.0530.2750.3770.1440.1340.2170.3710.0480.2430.1590.3170.3020.3350.2980.2830.3220.253
Total Other Income Expenses Net -0.037-11.9711.372-0.29.855-0.4870.427-0.0010.428-1.481-0.1829.447-0.0687.449-0-0.553.202-4.957-15.7962.3625-0.0746.8959.182-0.0790.62312.434-0.293-0.002-0.001-3.947-3.2052.0530.4583.9431.453-0.982-1.089
Income Before Tax 136.732-21.07953.71177.559130.0134.47772.63174.652109.00252.88861.76960.15281.0537.45429.98542.8449.11222.58215.73534.82222.3595.45320.44126.3628.34612.6278.01624.2662.41324.3757.67314.28813.80726.38715.769.78113.32611.454
Income Before Tax Ratio 0.446-0.1890.2740.4110.4350.2410.3580.3620.4150.2830.3140.3410.3950.2680.2080.3020.3410.210.1710.2670.2810.0520.2760.3720.1430.1410.210.3660.0480.2430.1560.2770.3540.3410.3280.3040.3240.254
Income Tax Expense 17.5331.1154.55710.20717.5295.9137.498.12815.329-5.4117.7157.85110.3281.8372.3574.0335.2331.9352.1443.2041.379-0.6531.1993.1050.5641.103-0.5912.5440.4023.0040.6121.7421.7732.7882.21.0611.8781.503
Net Income 119.199-22.19549.15367.352112.48128.56465.14166.52493.67358.29854.05452.30170.72335.61727.62838.80743.87820.64713.59131.61820.986.10619.24223.2577.78211.5248.60721.7222.01121.3717.0612.54612.03423.59913.568.72111.4489.951
Net Income Ratio 0.389-0.1990.2510.3570.3760.20.3210.3230.3570.3120.2750.2970.3450.2540.1920.2740.3050.1920.1480.2420.2640.0580.2590.3280.1330.1290.2260.3280.040.2130.1440.2430.3090.3050.2820.2710.2790.22
EPS 0.14-0.080.0590.0810.190.0480.110.110.160.10.190.180.180.0450.0940.130.0770.0760.0260.120.0380.0230.0380.0890.0150.040.0150.0640.0030.0720.0120.0620.030.110.0330.0450.030.064
EPS Diluted 0.14-0.080.0590.0810.190.0490.110.110.160.10.190.180.180.0450.0940.130.0770.0760.0260.120.0380.0230.0380.0890.0150.040.0150.0640.0030.0720.0120.0620.030.110.0330.0450.030.064
EBITDA 138.43229.11555.68495.078131.74547.0184.89986.442120.99963.88973.08669.4490.02845.54537.89550.52356.91929.92322.93440.61928.83211.48526.332.41615.65218.766.26715.27110.7323.41811.66521.56212.14433.34111.8178.78614.30914.883
EBITDA Ratio 0.4510.2620.2840.5040.4410.3290.4180.4190.4610.3420.3720.3940.4390.3250.2630.3570.3950.2790.2490.3110.3630.110.3550.4570.2680.2090.1640.2310.2150.2330.2370.4180.3120.430.2460.2730.3480.33